HomeUTHR • NASDAQ
United Therapeutics Corporation
$233.97
After Hours:
$233.97
(0.00%)0.00
Closed: Mar 18, 4:02:39 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$235.78
Day range
$229.55 - $237.00
Year range
$204.44 - $261.54
Market cap
11.01B USD
Avg Volume
444.60K
P/E ratio
11.81
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
614.70M25.07%
Operating expense
282.50M14.00%
Net income
217.10M64.35%
Net profit margin
35.3231.40%
Earnings per share
4.3619.68%
EBITDA
274.90M38.77%
Effective tax rate
26.51%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
2.99B5.47%
Total assets
7.17B18.57%
Total liabilities
1.18B-5.26%
Total equity
5.98B
Shares outstanding
47.06M
Price to book
1.85
Return on assets
9.20%
Return on capital
9.87%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
217.10M64.35%
Cash from operations
150.70M17.55%
Cash from investing
42.10M122.24%
Cash from financing
-92.80M-267.21%
Net change in cash
100.00M1,885.71%
Free cash flow
87.51M20.09%
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Employees
1,168
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu